Air Protein's $32 million Series A signals funding momentum in CO₂-based protein for human food

January 08, 2021
Emerging Ecosystems in Agrifood and Health More...
Very important

Kiverdi's spinoff Air Protein has raised a $32 million Series A led by ADM Ventures, Barclays, and GV (previously Google Ventures). Air Protein will use the funds to accelerate the development and commercialization of its CO2-based protein for meat substitutes as well as launch an innovation R&D lab and expand its team. This news comes shortly after Air Protein's key competitor Solar Foods raised an $18 million Series A. The significance: Air Protein and Solar Foods are solely pursuing human food markets, while most single-cell protein developers are initially targeting animal feeds. Clients should view the funding as a vote of confidence in CO2-based protein for food but remember that it will face uncertain regulatory and consumer hurdles.

For the original news article, click here .

Further Reading

Sustainable Bioproducts rebrands as Nature's Fynd, raises $80 million Series B round

News Commentary | March 25, 2020

This brings the company's total funding to $113 million. Breakthrough Energy Ventures and Generation Investment Management co‑led the round. Strategic investors ADM Ventures and Danone Manifesto Ventures participated again, previously contributing to the company's $33 million Series A round in ... Not part of subscription

InnovoPro's $15 million Series B indicates growing momentum for second-generation proteins

News Commentary | April 27, 2020

This Series B round was led by Jerusalem Venture Partners, with participation from several other strategic investors, bringing InnovoPro's total funding to $20.8 million. The company plans to use this fund to expand the production capacity of its chickpea protein concentrate as well as to focus on ... Not part of subscription

Qualitas Health raises $10 million to expand to the alternative protein market

News Commentary | January 13, 2021

The round was led by PeakBridge VC and joined by Minrav, Arancia, and other investors. Qualitas Health grows algae in open raceway ponds to produce omega‑3 supplements (under the iwi brand). The company will use the funding to further its sales, research, and clinical testing efforts and accelerate ... Not part of subscription